It means the product was never tested or manufactured to be injected into a person
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
Theres no limitation on their ability to produce any particular formulation, he said
These symptoms are usually mild and self-resolving
Some advanced users split their dose across 2x per week (e.g., Monday and Friday), which may offer more stable blood levels but is more complicated practically